4//SEC Filing
Pauls Dietrich John 4
Accession 0001235802-22-000121
CIK 0001401040other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 8:56 PM ET
Size
5.4 KB
Accession
0001235802-22-000121
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Purchase
Voting Common Shares, no par value per share
2022-11-16$1.21/sh+20,000$24,200→ 55,804 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.17 to $1.21, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001760123
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 8:56 PM ET
- Size
- 5.4 KB